Gianpaolo Pozzato on Advancing Hemostasis Automation Through HemoCell and Axonlab Collaboration
Gianpaolo Pozzato, EEMEA Hemostasis Product Manager, shared on LinkedIn:
”Kicked off 2026 with a focused visit to Basel, Switzerland, returning to our HemoCell installation to further optimize performance and resilience.
Why the Werfen dedicated, specialized automation matters in Hemostasis:
– Consistent, standardized workflows
– Reliable TAT even at peak load
– Strong QC, full traceability, and smart reflex testing
This trip was about aligning system capabilities with the evolving complexity of Hemostasis workloads, and translating user feedback into measurable operational gains.
Grateful to Daria Prokudina, MD for the expert on‑site support, and to our Partner Axonlab international for the excellent collaboration and hospitality.
Together we keep raising the bar for patient‑centric diagnostics.”
Stay updated with Hemostasis Today.
-
Jan 27, 2026, 14:06Dmitrii V Kalinin Shares A PhD Opportunity: Hardiman Scholarship
-
Jan 27, 2026, 13:48Filippo Cademartiri: 3 Biomarkers Are Better Than 1: Refining ASCVD Risk in MESA
-
Jan 27, 2026, 12:27Martin Haluzík on Residual Cardiovascular Risk in Coronary Artery Disease
-
Jan 27, 2026, 12:18Stuart Phillips: Strong Bodies Are Good, Informed Bodies Are Better!
-
Jan 27, 2026, 12:07Daniel Torrent: This Should Be An Ice Cold Take… But Veins Aren’t Arteries
-
Jan 27, 2026, 09:17Paolo Zamboni on CCSVI Associated to Multiple Sclerosis
-
Jan 27, 2026, 09:02Rowan Paul: Platelet Dose Determines Success in PRP Therapy
-
Jan 27, 2026, 08:48Uriel Suárez: Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome
-
Jan 27, 2026, 08:23Rossella Crescitelli on Platelets’ and PEVs’ Association with Lung Cancer Metastases